MARKI HALL: Open Payments
NPI 1770109555 · ALCOA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 19 payments from 6 companies in 2025. Trend: 2023 $77 · 2024 $363 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $137 |
| Novo Nordisk Inc | 4 | $77 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
| Lilly USA, LLC | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: AIRSUPRA, Ozempic, BREZTRI, GVOKE HYPOPEN, TRELEGY ELLIPTA, Rybelsus, FARXIGA, SHINGRIX.
Industry payments across TN — which companies pay providers there.
